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Abstract
Purpose: The ‘step-by step’ principle was introduced into the European Union legislation on genetically modified
organisms as a means to cope with uncertainty about environmental risks from the release of genetically modified
organisms into the environment. The approval process is orientated along the stepwise reduction of containment
which reflects a precautionary approach towards the risks of genetically modified organism release. Thus, the
gradual reduction of containment should keep pace with the gradual generation of risk-related knowledge. This
paper strives to clarify the meaning, legal status and practical importance of the principle. It also looks at whether
non-European Union countries have adopted the principle as well, and how they practice it.
Methods: The article is based on research of the relevant legal texts, court cases and legal literature. In addition, a
number of dossiers of applications for the European Union authorisation of release and placing on the market of
genetically modified seed were analysed.
Results and conclusions: Although ‘step-by-step’ is not a precise legal rule it does have legal meaning as a
principle guiding the risk assessment and management of genetically modified organism introduction into the
environment. Assuming a process of gradual reduction of containment and scaling up of release ranging from
closed systems via experimental release to cultivation the ‘step-by-step principle’ requires that the knowledge on
environmental risks of genetically modified organisms should be generated on stages previous to the ones where
the risk can result in damage. The analysis of the legislation of China, the United States of America and Brazil
showed a differentiated approach towards the step-by-step principle.
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Analysis
’Step-by-step’ in the relevant legal texts
The ‘step-by-step’ principle was introduced by Directive
2001/18/EC [1] where it appears as numbers (24) and
(25) of the preamble:
’(24) The introduction of GMOs into the environ-
ment should be carried out according to the “step by
step” principle. This means that the containment of
GMOs is reduced and the scale of release increased
gradually, step by step, but only if evaluation of the
earlier steps in terms of protection of human health
and the environment indicates that the next step can
be taken.
(25) No GMOs, as or in products, intended for
deliberate release are to be considered for placing on
the market without first having been subjected to
satisfactory field testing at the research and develop-
ment stage in ecosystems which could be affected by
their use.’
Directives must be transposed into Member State law
allowing them some legislatory discretion. In German
law, for example, ‘step-by-step’ is framed in a rather
broad language requiring that the risk assessment shall
be based on experiences made on previous steps
(GenTVfV 1996 Sec. 5 (2), 6 (2) [2]). Contrastingly, the
Austrian Gentechnikgesetz [2] establishes ‘step-by-step’
as a binding precondition of authorisations. See Section
3 (3) which reads:
’The release of GMOs may only be performed step
by step meaning that the containment of the GMOs
may stepwise be unclenched and the scale of release
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only be increased if the assessment of the earlier
step indicates that the next step is compatible with
the precautionary principle.’
A similar rule is contained in Art. 6 (2) of the Swiss
Gentechnikgesetz ([2,3]: 170).
Scope of application of the step-by-step principle
The principle is applicable to all authorisation proce-
dures concerning the experimental release and the pla-
cing on the market of genetically modified organisms
(GMOs) which results in the subsequent introduction of
GMOs into the environment.
While Regulation (EC) 1829/2003 [4] establishes a
special authorization regime for food and feed, including
also GMOs for cultivation of food and feed, Art. 6 (4)
and Art. 18 (4) of the same regulation refer to the envir-
onmental safety requirements of Directive 2001/18/EC
[1]which also include the step-by-step principle.
The use of the term ‘step-by-step’ in the GMO regime
Besides the levels of containment, the phases of risk
assessment (hazard identification, evaluation of adverse
effects, evaluation of likelihood of adverse effects, esti-
mation of risk, etc.) are also called steps.a It would be
less confusing if for the ‘steps’ of risk assessment the
term ‘tiers’ was used instead. The levels of risk assess-
ment (DNA, genome, organism, population, ecosystem)
are sometimes also called steps. It is suggested to call
them organismic and ecological levels.
The difference between the step-by-step and the case-by-
case principles
’Case-by-case’ (see Art. 4 (3) Directive 2001/18/EC [1])
means that risk information about one GMO and its
release cannot without proper scrutiny be transferred to
other GMOs. It allows, however, facilitating procedures
if sufficient information has been obtained on certain
GMOs and if the release of the GMO or the type of the
GMO shall be repeated or performed at different sites
(see Art. 7 Directive 2001/18/EC [1]). By contrast, ‘step-
by-step’ can be understood as an auxiliary tool within
the case-by-case approach. It is a tool helping to struc-
ture the information generation for certain GMOs.
The legal status of the step-by-step principle
Reflecting that the principle is part of considerations but
not of the working text of Directive 2001/18/EC [1] it is
(in its quality as European Union (EU) law) not a self-
standing requirement of authorisations [5]. It neverthe-
less has a legal value. First, it is a general principle
explaining the overall philosophy for the introduction of
GMOs into the environment, i.e. the stepwise reduction
of containment going along with the accumulation of
knowledge. Second, it is an interpretation guidance for
the working provisions of the directive thus helping to
specify the scope of documents to be submitted and the
understanding of the material yardsticks of risk
assessment.
Basic information requirements for approval
’Step-by-step’ does not mean that the release of GMOs
can simply be based on the state of the knowledge that
is at the disposal of the competent authority. Rather, the
applicant for approval bears the burden of submitting
evidence that no adverse effect will be caused by the
release. This implies that the applicant must if needed
conduct certain tests, be it by his own initiative or upon
request by the authority.
There are four requirements which the applicant must
fulfil in that respect, and which if unfulfilled allows the
authority to reject the application. These can be
regarded as minimum postulates of the step-by-step
principle:
- Submission of data on the parent organism, the reci-
pient organism, the GMO and the effects of the GMO
on human health, plant and animal health and the
environment as listed in Art. 5 (3) and Annex III B
Directive 2001/18/EC [1].
- Submission of an environmental risk analysis (ERA)
as expounded by Annex II Directive 2001/18/EC [6]. A
proper analysis of this kind will need to present results
of basic tests which allow the authority to determine
what kind of risks may be caused. The scope of this sort
of tests seems however not to be clear yet. Some stan-
dardization has been achieved by [6] and [7].
- Execution and submission of additional tests on
demand of the authority if there is grounded hypothesis
for an adverse effect on health or the environment by
the submitted ERA. This power can be derived from the
requirement of Art. 4 Directive 2001/18/EC [1] that no
adverse effect shall be caused.
- Submission of uncertainty analyses on all test results
concerning health and environmental risks.b
Step-by-step in practice
There are different situations during the application
phase when reference to the step-by-step principle may
be of importance.
State of science and technology
It is not allowed for the operator to argue that he/she
cannot carry out a safety measure because the relevant
science or technology is not yet developed. The step-by-
step principle shall ensure that the state of science and
technology is developed throughout the previous steps
such that an adequate risk assessment can be made. If
further previous scientific investigation is necessary at
the stage of the administrative decision, the
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authorisation of experimental release or placing on the
market must be denied.
Residual risk
The analysis of authorisation procedures shows that risk
assessors and competent authorities frequently argue
that additional studies are not needed because the
assumed risk is ‘negligible’ or ‘tolerable’. There are dif-
ferent reasons why society might decide to acquiesce
with residual risk: The limits of scientific understanding
which advises to apply ‘praktische Vernunft’ (practical
reason) [8], and, alternatively or in addition, considera-
tions of benefits drawn from new technologies. The
authors suggest that a residual risk should only be
accepted if it is balanced by a benefit. Such benefit is
scientific progress at the stage of small or large-scale
release and more environmentally friendly agriculture at
the stage of placing on the market [9].
Reference to other studies
The operator can ask to be freed from certain tests if
the relevant knowledge is available from other studies,
under the condition that the other studies are valid and
reliable. In particular, given possible effects from the
positioning of donor traits in the recipient genome the
other study must have been made on the same GMO.c
Likewise, testing conditions and methods must be simi-
lar. Our analysis of application dossiers shows however
that the conditions of validity and reliability are often
not respected (StepKo 2011, Draft final report June
2011. on file with authors, ch. 2).
Blanket reference
The operator can ask to be freed from certain tests
referring to the fact that on previous steps no adverse
effects have been noticed, but only under the condition
that the waiver relates to a risk hypothesis which was
tested within the previous step. The blanket formula
that no adverse effect was noticed on previous steps is
not an acceptable proof, because it is not guaranteed
that appropriate tests have been performed, for there is
no requirement on any step to actively generate knowl-
edge for the next step. Neither the case specific moni-
toring nor the general surveillance obligations require
such active attitude (see below).
Submission of data from earlier steps
The authority is entitled to ask the operator to submit
all risk information obtained from earlier steps. Annex
III B No D 13 Dir 2001/18 says that required for a noti-
fication of release is ‘information about previous releases
of the genetically modified plant, if applicable’. Even
more explicit is Art. 13 (2) Dir 2001/18: ‘The notifica-
tion shall contain: (a) the information required in
Annexes III and IV. This information shall [...] include
information on data and results obtained from research
and developmental releases concerning the impact of
the release on human health and the environment’ [1].
It should be noted that the obligation to submit the
information from tests within earlier steps extends both
to positive and negative results. As also unpredicted
effects must be explored the submission of data is not
bound to risk hypotheses.
Authority’s use of own knowledge
Although the risk assessment must be prepared by the
operator, the competent authorities must generate and
use their own administrative knowledge in order to ela-
borate their own views. This follows from the so-called
investigation principle that characterizes administrative
procedures. In any case, the notifier must be given
opportunity to comment on the information before the
decision is taken.
Use of information of other notifiers
The authority is entitled to use risk information it has
obtained from other applications if the other applicant gives
his/her consent, Art. 6 (3), 13 (4) Directive 2001/18/EC [1]
and Art. 31 Regulation (EC) 1829/2003 [4]. If the consent is
refused the applicant must produce the data anew.
Monitoring as an additional step within step-by-step
Within certain limits the monitoring can be seen as an
additional step of the step-by-step approach. The objec-
tive of monitoring is to identify effects of the GMO(s) on
human health or the environment which have not been
discovered at the stage of the environmental risk assess-
ment. For deliberate releases this is generally expressed
in Art. 6 (2) (v) Directive 2001/18/EC [1]. For the placing
on the market, monitoring is differentiated into case-spe-
cific monitoring (i.e. the confirmation of any assumption
regarding the effect of the GMO) and general surveil-
lance (i.e. the identification of adverse effects which were
not anticipated). The possibility of requiring monitoring
does however not allow the competent authority to shift
the testing of grounded risk hypotheses to the monitor-
ing stage. As said earlier, it must deny authorisation if
the test could have been performed within previous steps.
No obligation for proactive testing
Apart from the powers to order the control of the cur-
rent test and to monitor effects, neither EU law nor
national law endows authorities with powers to ask for
tests whose sole purpose is to generate information rele-
vant for the subsequent step. However, this does not
hinder authorities to require, on the subsequent step,
risk information which should have been generated on
previous steps. It may be advisable that competent
authorities develop non-binding guidance which advises
what tests should be performed on what steps.d
Comparative law: the step-by-step principle in non-EU
countries
We have selected for further study the USA, Brazil and
China because they have a long-standing practice of
authorising the release of GMOs.
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In the USA, there is no comprehensive law on genetic
engineering. Rather, gene technology is spread over the
already existing laws controlling risks from releases of
products. For instance, genetically modified seeds are
regulated either by the Plant Protection Act, the Federal
Insecticide, Fungicide and Rodenticide Act or the Toxic
Substances Control Act depending on whether they may
cause adverse effects on plants, have insecticide proper-
ties or may have other toxic effects [10]. The National
Environmental Pollution Act (NEPA) requires to pre-
pare an environmental impact statement if a preliminary
test indicates that a modified plant will be ‘significantly
affecting the quality of the human environment.’e The
step-by-step principle, however, is not mentioned, at
least not on the level of laws. Rather, it appears as part
of a guidance paper.f
’Development of organisms for agricultural or envir-
onmental applications should be conducted in a
stepwise fashion, moving, where appropriate, from
the laboratory to the growth chamber and green-
house, to limited field testing and finally, to large-
scale field testing.’
This means that step-by-step is a general principle
guiding research and development, but no specific
requirement concerning individual authorisation proce-
dures. It is true, however, that insofar as an EIA is
required previous tests are necessary and thus some
kind of step-by-step does materialize.
In Brazil, there is a general law regulating gene tech-
nology - the Law No. 11.105 of 24 March 2005 ([11]:
1073-1076). However, this law does not establish a step-
by-step principle. The competent authority - the
National Biosafety Technical Commission (CTNBio) -
although being by the law endowed with powers to
establish principles of risk assessment on the sublegal
level has not laid down a step-by-step principle, neither
in a general nor in a specific sense.g
In China, there is a special and comprehensive regu-
lation on the safety of agricultural GMOs adopted in
2001 (Haigen Xu (2009) Unpublished analysis of Chi-
nese law on genetically modified organisms, contribu-
tion to the StepKo-project). It contains rather specific
provisions on the stepwise development and testing of
agricultural GMOs. The relevant provisions of the Reg-
ulation read:
Article 13. The testing of agricultural GMOs shall
generally go through three stages, i.e. restricted field-
testing, enlarged field-testing and productive testing.
The ‘restricted field-testing’ means a small-scale test
conducted within a contained system or under con-
trolled conditions.
The ‘enlarged field-testing’ means a medium-scale
test conducted under natural conditions with appro-
priate safety control measures.
The productive testing means a large-scale test prior
to commercial production and application.
Article 14. When an agricultural GMO needs to
move on to the stage of restricted field-testing after
the completion of research in laboratory, the organi-
zation conducting the test shall report to the compe-
tent agricultural administrative department of the
State Council.
Further articles provide that reports on the results of
earlier stages must be submitted when consent is
searched for the next step. However, the material yard-
stick for authorisation is framed in rather vague terms.
See Art. 1 which reads:
’These Regulations are formulated for the purposes
of strengthening safety administration of agricultural
genetically modified organisms (hereafter referred to
as agricultural GMOs), safeguarding human health
and safety of animals, plants and microorganisms,
protecting the environment, and promoting research
on agricultural GMOs.’
The overview of the three legislations shows that they
starkly vary concerning the step-by-step principle. Brazil
does not have it at all, the US has it as a general princi-
ple of policy, and China has it as a specific rule for the
testing of GMOs. While it could be expected that it
induces a particular cautious practice in China, the sub-
stantive yardsticks guiding the stepwise testing are not
as strict and precautionary as those required by EU leg-
islation. In conclusion, the step-by-step principle seems
to have failed to move the three pro-GMO states into a
direction which is as precautionary as the EU practice,
although for different reasons: because it was not pre-
scribed at all (Brazil), because it was not laid out as a
specific requirement of authorisations (USA), or because
it was not guided by precautionary substantive standards
(China).
Endnotes
aSee Annex II to Directive 2001/18/EC, ch. C [6].
bThis is general requirement of any sound science but
it is also mentioned in [6] ch. 3 and [7] ch. 2.3.3.8.
cThis may be different concerning the study of effects
of the parental lines.
dSee for a suggestion in that direction (StepKo 2011,
Draft final report June 2011, on file with authors, ch. 4).
e42 U.S.C. Section 4332(2)(C). The courts interprete
this to mean that the agency must take a ‘hard look’
whether these conditions are given. See the landmark
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decision of the US District Court [12] for the Northern
District of Califormia of 13 February 2007 (Geertson
Seed Farms, 570 F. 3d 1130). The court quashed the
decision of the competent authority to deregulate an
herbicide-resistant alfalfa. The Supreme Court reversed
the judgement but not in relation to the quashing of the
agency’s decision. Monsanto vs Geertson Seed Farms,
No. 09-475, Decision of 21 June, 2010.
fRecommendations Specific for Environmental and
Agricultural Applications, Executive Office of the Presi-
dent, Office of Science and Technology Policy, Coordi-
nated Framework for Regulation of Biotechnology, 51
FR 23302 June 26, 1986. http://usbiotechreg.nbii.gov/
CoordinatedFrameworkForRegulationOfBiotechnol-
ogy1986.pdf
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